These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 26435296)

  • 1. Open-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler's syndrome).
    Panicker JN; Seth JH; Khan S; Gonzales G; Haslam C; Kessler TM; Fowler CJ
    BJU Int; 2016 May; 117(5):809-13. PubMed ID: 26435296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of double-blind placebo-controlled crossover study of sildenafil citrate (Viagra) in women suffering from obstructed voiding or retention associated with the primary disorder of sphincter relaxation (Fowler's Syndrome).
    Datta SN; Kavia RB; Gonzales G; Fowler CJ
    Eur Urol; 2007 Feb; 51(2):489-95; discussion 495-7. PubMed ID: 16884844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Videourodynamic factors predictive of successful onabotulinumtoxinA urethral sphincter injection for neurogenic or non-neurogenic detrusor underactivity.
    Jiang YH; Jhang JF; Chen SF; Kuo HC
    Low Urin Tract Symptoms; 2019 Jan; 11(1):66-71. PubMed ID: 29024564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blind, placebo controlled pilot study of intradetrusor injections of onabotulinumtoxinA for the treatment of refractory overactive bladder persisting following surgical management of benign prostatic hyperplasia.
    Chughtai B; Dunphy C; Lee R; Lee D; Sheth S; Marks L; Kaplan SA; Te AE
    Can J Urol; 2014 Apr; 21(2):7217-21. PubMed ID: 24775575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breaking the vicious circle: Onabotulinum toxin A in children with therapy-refractory dysfunctional voiding.
    't Hoen LA; van den Hoek J; Wolffenbuttel KP; van der Toorn F; Scheepe JR
    J Pediatr Urol; 2015 Jun; 11(3):119.e1-6. PubMed ID: 25794865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the appearance of the urethral pressure profile trace correlate with the sphincter EMG findings in women with voiding dysfunction?
    Sihra N; Malde S; Panicker J; Kightley R; Solomon E; Hamid R; Ockrim J; Greenwell TJ; Pakzad M
    Neurourol Urodyn; 2018 Feb; 37(2):751-757. PubMed ID: 28678412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of urethral injection of botulinum A toxin in the treatment of voiding dysfunction after radical hysterectomy.
    Kuo HC
    Urol Int; 2005; 75(3):247-51. PubMed ID: 16215314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes.
    Sacco E; Tienforti D; Bientinesi R; D'Addessi A; Racioppi M; Pinto F; Totaro A; Vittori M; D'Agostino D; Bassi P
    Neurourol Urodyn; 2014 Jan; 33(1):142-6. PubMed ID: 23868794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A injection to the bladder neck and urethra for medically refractory lower urinary tract symptoms in men without prostatic obstruction.
    Chen JL; Chen CY; Kuo HC
    J Formos Med Assoc; 2009 Dec; 108(12):950-6. PubMed ID: 20040460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary retention in female OAB after intravesical Botox injection: who is really at risk?
    Miotla P; Cartwright R; Skorupska K; Bogusiewicz M; Markut-Miotla E; Futyma K; Rechberger T
    Int Urogynecol J; 2017 Jun; 28(6):845-850. PubMed ID: 27889830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of urethral sphincter onabotulinumtoxinA injection for urethral sphincter hyperactivity.
    Jiang YH; Chen SF; Jhang JF; Kuo HC
    Neurourol Urodyn; 2018 Nov; 37(8):2651-2657. PubMed ID: 29797345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External urethral sphincter electromyography in asymptomatic women and the influence of the menstrual cycle.
    Tawadros C; Burnett K; Derbyshire LF; Tawadros T; Clarke NW; Betts CD
    BJU Int; 2015 Sep; 116(3):423-31. PubMed ID: 25600712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of botulinum toxin in external urethral sphincter by transperineal way guided transrectal ultrasound and electromyography on chronic urinary retention due to spinal cord injury].
    Romero-Cullerés G; Conejero-Sugrañes J; González-Viejo MÁ; Bruno-Montoro J; López-Guillen P; Abenoza-Guardiola M
    Med Clin (Barc); 2011 Sep; 137(8):346-8. PubMed ID: 21367435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gynaecological pathology in women with Fowler's syndrome.
    Karmarkar R; Abtahi B; Saber-Khalaf M; Gonzales G; Elneil S
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():54-7. PubMed ID: 26340452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of Fowler's syndrome predicts successful long-term outcome of sacral nerve stimulation in women with urinary retention.
    De Ridder D; Ost D; Bruyninckx F
    Eur Urol; 2007 Jan; 51(1):229-33; discussion 233-4. PubMed ID: 16860462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fowler's Syndrome: diagnostic and therapeutic challenge].
    Bártolo M; Martins L; Martins F
    Acta Med Port; 2011; 24(4):645-8. PubMed ID: 22521026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum Toxin A Injections Into Pelvic Floor Muscles Under Electromyographic Guidance for Women With Refractory High-Tone Pelvic Floor Dysfunction: A 6-Month Prospective Pilot Study.
    Morrissey D; El-Khawand D; Ginzburg N; Wehbe S; O'Hare P; Whitmore K
    Female Pelvic Med Reconstr Surg; 2015; 21(5):277-82. PubMed ID: 25900057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum A toxin urethral injection for the treatment of lower urinary tract dysfunction.
    Kuo HC
    J Urol; 2003 Nov; 170(5):1908-12. PubMed ID: 14532805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction.
    Kao YL; Huang KH; Kuo HC; Ou YC
    Toxins (Basel); 2019 Dec; 11(12):. PubMed ID: 31847090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the true catheterization rate after intravesical onabotulinumtoxinA injection?
    Patel DN; Jamnagerwalla J; Houman J; Anger JT; Eilber KS
    Int Urogynecol J; 2018 Jul; 29(7):1005-1009. PubMed ID: 28808734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.